Global Medical REIT Dirección
Dirección controles de criterios 4/4
Global Medical REIT's El consejero delegado es Jeff Busch , nombrado en Aug 2015, tiene un mandato de 8.33 años. la remuneración anual total es $1.84M , compuesta por 35.3% salario y 64.7% primas, incluidas acciones y opciones de la empresa. posee directamente 0.066% de las acciones de la empresa, por valor de $468.67K . La antigüedad media del equipo directivo y del consejo de administración es de 7.8 años y 7.8 años respectivamente.
Información clave
Jeff Busch
Chief Executive Officer (CEO)
US$2.2m
Compensación total
| Porcentaje del salario del CEO | 32.1% |
| Permanencia del CEO | 8.7yrs |
| Participación del CEO | 0.07% |
| Permanencia media de la dirección | 8.1yrs |
| Promedio de permanencia en la Junta Directiva | 8.1yrs |
Actualizaciones recientes de la dirección
Recent updates
Global Medical REIT Offers A 9.3% Dividend Yield And 7.6% On The Preferreds
Mar 09Global Medical REIT: Nothing Promising After Q4 Results, Still A Hold
Feb 29Global Medical REIT: Patient In Stable Condition, Risk Priced In
Feb 02Global Medical REIT: A Hold Despite Improving Performance
Nov 21Global Medical: 7.7% Yielding Preferreds Are Expensive, A Look At Alternatives
Oct 16Global Medical REIT: Revisiting Dividend Assumption After Q2 Results
Sep 10Global Medical REIT: Higher For Longer Scenarios Will Stress The REIT
Aug 04Global Medical: The 9.5% Yield Appears Covered Despite Pressure From Interest Rates
Jun 29If EPS Growth Is Important To You, Global Medical REIT (NYSE:GMRE) Presents An Opportunity
Mar 13
Global Medical REIT: A Strong Buy At Attractive Valuations And 7.8% Dividend Yield
Jan 27Global Medical REIT: Brace For A Hawkish Fed
Dec 25Global Medical REIT GAAP EPS of $0.12
Nov 02Global Medical REIT: Passive Income Machine With Safe 10.8% Yield
Oct 21Global Medical REIT stock drops after BMO downgrades on elevated leverage
Oct 06Global Medical REIT Now Has A 9% Recession Resistant Yield
Sep 28Global Medical REIT declares $0.21 dividend
Sep 09Global Medical REIT: Significant Upside Potential, Along With A High Yielding Dividend
Aug 18Global Medical REIT: Market Dislocation From First To Worst, Opportunity Refreshed
Jun 29Global Medical REIT: Another Solid Quarter From This Growing Healthcare REIT
May 17Global Medical REIT: A Breakdown Of My Favorite Healthcare REIT
Mar 03Global Medical REIT: Success Like This Draws A Crowd
Dec 29Global Medical REIT And Medical Properties Are Clear Winners In The Mispriced Healthcare Sector
Oct 20The Growth Story Remains Intact At Global Medical REIT
Oct 04Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$700k | US$15m |
| Sep 30 2023 | n/a | n/a | US$16m |
| Jun 30 2023 | n/a | n/a | US$21m |
| Mar 31 2023 | n/a | n/a | US$11m |
| Dec 31 2022 | US$2m | US$650k | US$13m |
| Sep 30 2022 | n/a | n/a | US$17m |
| Jun 30 2022 | n/a | n/a | US$12m |
| Mar 31 2022 | n/a | n/a | US$13m |
| Dec 31 2021 | US$2m | US$600k | US$12m |
| Sep 30 2021 | n/a | n/a | US$9m |
| Jun 30 2021 | n/a | n/a | -US$5m |
| Mar 31 2021 | n/a | n/a | -US$7m |
| Dec 31 2020 | US$3m | US$298k | -US$8m |
| Sep 30 2020 | n/a | n/a | -US$8m |
| Jun 30 2020 | n/a | n/a | US$3m |
| Mar 31 2020 | n/a | n/a | US$4m |
| Dec 31 2019 | US$455k | n/a | US$3m |
| Sep 30 2019 | n/a | n/a | US$9m |
| Jun 30 2019 | n/a | n/a | US$9m |
| Mar 31 2019 | n/a | n/a | US$8m |
| Dec 31 2018 | US$396k | n/a | US$8m |
| Sep 30 2018 | n/a | n/a | US$440k |
| Jun 30 2018 | n/a | n/a | US$535k |
| Mar 31 2018 | n/a | n/a | -US$23k |
| Dec 31 2017 | US$673k | n/a | -US$2m |
Compensación vs. Mercado: La compensación total de Jeff ($USD1.84M) es aproximadamente el promedio para empresas de tamaño similar en el mercado US ($USD2.12M).
Compensación vs. Ingresos: La compensación de Jeff ha sido consistente con los resultados de la empresa en el último año.
CEO
Jeff Busch (63 yo)
8.7yrs
Permanencia
US$2,181,100
Compensación
Mr. Jeffrey M. Busch, also known as Jeff, is Chairman of the Board at Theralink Technologies, Inc. (formerly known as OncBioMune Pharmaceuticals, Inc.). since June 2020. He is the Chairman of Avant Diagnos...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 8.7yrs | US$2.18m | 0.066% $ 373.8k | |
| CFO & Treasurer | 6.7yrs | US$1.41m | 0% $ 0 | |
| Chief Operating Officer | 8.1yrs | US$935.78k | 0.00076% $ 4.3k | |
| Chief Investment Officer | 8.8yrs | US$1.34m | 0% $ 0 | |
| General Counsel & Corporate Secretary | 6.9yrs | US$872.70k | 0% $ 0 | |
| Investor Relations Professional | no data | sin datos | sin datos |
8.1yrs
Permanencia media
50yo
Promedio de edad
Equipo directivo experimentado: GMREEl equipo directivo de la empresa es veterano y experimentado (7.8 años de antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 9.6yrs | US$2.18m | 0.066% $ 373.8k | |
| Independent Director | 8.7yrs | US$155.71k | 0.012% $ 67.3k | |
| Lead Independent Director | 8.7yrs | US$183.21k | 0.012% $ 66.5k | |
| Independent Director | 5.8yrs | US$177.77k | 0% $ 0 | |
| Independent Director | 5.9yrs | US$203.10k | 0% $ 0 | |
| Independent Director | 8.1yrs | US$153.48k | 0% $ 0 | |
| Director | 8.1yrs | sin datos | 0% $ 0 |
8.1yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: La junta directiva de GMRE se considera experimentada (7.8 años de antigüedad promedio).